circRNA basic information
circBase ID: mmu_circ_0000860
Name: -
Synonym: -
Host Gene: -
Genomic location(hg19): -
Genomic location(hg38): -
Subcellular localization: not tested
 
 
 
 
 
 
 
Disease basic information
MONDO ID:
0005233
MONDO name: non-small cell lung carcinoma
Disease details: non-small cell lung cancer / NSCLC
Disease DO ID:
3908
Disease MeSH ID:
D002289
Disease NCIt ID:
C2926
Disease ICD11 ID:
-
Disease OMIM ID:
-
Species: Mouse
Species details: Mus musculus
Tissue specimen:

subcutaneous tumours; tumour tissues

Cell lines:

LLC

In vivo animal model:

syngeneic model

circRNA-disease information
Expression pattern:
UN
Associated gene: QKI6, PD-L1, STUB1, OTUB1
Associated microRNA: -
Biological function: Inhibits subcutaneous tumour growth in vivo and increases CD8 infiltration/activation markers; associated with reduced PD-L1 protein in tumours.
Molecular mechanism: In tumours from mmu_circ_0000860-overexpressing cells, QKI6 and STUB1 proteins are increased while PD-L1 and OTUB1 proteins are reduced, consistent with enhanced PD-L1 ubiquitination/degradation.
Biological pathway or process:

proliferation (inhibits); immune regulation (promotes); ubiquitination (promotes)

Detected method:
Q
Validation methods:

RT-qPCR; Western Blot; Transfection; In Vivo Animal Model; H&E Staining; IHC (Immunohistochemistry)

Clinical significance:

-

Description:

In a mouse syngeneic tumour model using LLC cells, overexpression of mmu_circ_0000860 suppresses tumour growth and increases CD8 staining in tumours. Tumour protein changes (higher QKI6/STUB1 and lower PD-L1/OTUB1) align with reduced immune evasion via PD-L1 downregulation.

Confidence score:

0.5358

Other information
Title:

Circ_0074158 and QKI6: A regulatory axis for PD-L1 ubiquitination and immune evasion in NSCLC.

Journal: Cancer immunology, immunotherapy : CII
Published: 2025
PubMed ID: 40931215
Study type:

biological research

Data availability: The data supporting the findings of this study are included within the article.
Code availability: -